Urgently seeks meeting with the BRTX Board to discuss opportunities to unlock value for all shareholders

MIAMI, May 27, 2026 /CNW/ - Kaos Capital Ltd. ("Kaos Capital" or "we"), a Miami-based hedge fund focused on activist investing, today announced that it has acquired 4.9% of the issued and outstanding common stock of BioRestorative Therapies, Inc. ("BRTX" or the "Company").

This ownership stake was acquired in the open market through normal course stock purchases. Kaos Capital believes that BRTX represents a compelling opportunity, as the public vehicle may be better positioned for a strategic pivot into the AI space.

Unfortunately, BRTX shareholders are not currently gaining meaningful value from the existing business. We at Kaos feel that the Company should explore a comprehensive strategic review and consider a pivot into a broader range of AI opportunities.

As a significant shareholder, Kaos Capital is committed to working constructively with the BRTX Board of Directors and management to unlock shareholder value. To that end, we intend to seek an immediate meeting with the Board to discuss the Company's strategy, operations, corporate governance, and potential pathways—including a possible pivot into AI—to enhance value for all shareholders.

We look forward to engaging in a productive dialogue that prioritizes the best interests of BRTX and its shareholders.